1. Home
  2. ELEV vs RAVE Comparison

ELEV vs RAVE Comparison

Compare ELEV & RAVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ELEV
  • RAVE
  • Stock Information
  • Founded
  • ELEV 2019
  • RAVE 1958
  • Country
  • ELEV United States
  • RAVE United States
  • Employees
  • ELEV N/A
  • RAVE N/A
  • Industry
  • ELEV Biotechnology: Pharmaceutical Preparations
  • RAVE Restaurants
  • Sector
  • ELEV Health Care
  • RAVE Consumer Discretionary
  • Exchange
  • ELEV Nasdaq
  • RAVE Nasdaq
  • Market Cap
  • ELEV 22.6M
  • RAVE 39.1M
  • IPO Year
  • ELEV 2021
  • RAVE N/A
  • Fundamental
  • Price
  • ELEV $0.39
  • RAVE $2.87
  • Analyst Decision
  • ELEV Hold
  • RAVE
  • Analyst Count
  • ELEV 6
  • RAVE 0
  • Target Price
  • ELEV $1.77
  • RAVE N/A
  • AVG Volume (30 Days)
  • ELEV 2.4M
  • RAVE 24.9K
  • Earning Date
  • ELEV 08-05-2025
  • RAVE 05-08-2025
  • Dividend Yield
  • ELEV N/A
  • RAVE N/A
  • EPS Growth
  • ELEV N/A
  • RAVE 25.31
  • EPS
  • ELEV N/A
  • RAVE 0.19
  • Revenue
  • ELEV N/A
  • RAVE $12,240,000.00
  • Revenue This Year
  • ELEV N/A
  • RAVE N/A
  • Revenue Next Year
  • ELEV N/A
  • RAVE N/A
  • P/E Ratio
  • ELEV N/A
  • RAVE $15.32
  • Revenue Growth
  • ELEV N/A
  • RAVE 3.35
  • 52 Week Low
  • ELEV $0.22
  • RAVE $1.70
  • 52 Week High
  • ELEV $3.28
  • RAVE $3.36
  • Technical
  • Relative Strength Index (RSI)
  • ELEV 60.95
  • RAVE 63.32
  • Support Level
  • ELEV $0.36
  • RAVE $2.48
  • Resistance Level
  • ELEV $0.39
  • RAVE $2.83
  • Average True Range (ATR)
  • ELEV 0.01
  • RAVE 0.11
  • MACD
  • ELEV -0.00
  • RAVE 0.03
  • Stochastic Oscillator
  • ELEV 92.86
  • RAVE 89.36

About ELEV Elevation Oncology Inc. Common stock

Elevation Oncology Inc is an oncology company focused on the development of selective cancer therapies to treat patients across a range of solid tumors with unmet medical needs. Its product candidate, EO-3021 (also known as SYSA1801 or CPO102), is an ADC comprised of a fully human anti-Claudin 18.2 immunoglobulin G1 (IgG1) monoclonal antibody (mAb) site-specifically conjugated with a cleavable linker to the cytotoxic monomethyl auristatin E (MMAE) payload. Claudin 18.2 is overexpressed in several types of cancers, including gastric, esophageal, pancreatic, ovarian and lungon.

About RAVE Rave Restaurant Group Inc.

Rave Restaurant Group Inc operates and franchises pizza buffet, delivery/carry-out, express restaurants, and ghost kitchens. It operates restaurants under the brand name, Pizza Inn, and Pie Five Pizza Company. It has three operating segments. The Pizza Inn and Pie Five Franchising segments establish franchisees, licensees, and territorial rights. The company-owned restaurant segment includes sales and operating results for all company-owned restaurants. The Pizza Inn Franchising segment accounts for the company's revenue. Geographically, it generates the majority of the revenue from the United States.

Share on Social Networks: